Funds support groundbreaking studies on psilocybin, MDMA, and LSD
Fundamental Crowdfunding Campaign from FUNDAMENTAL on Vimeo.
Press Release – NEW YORK, NY (PRWEB) MAY 09, 2017: Today, Fundamental announced the launch of a crowdfunding campaign to support critical research into psychedelic-assisted therapies in mental health and cognition. This is the first large-scale fundraising campaign with an aim to secure funding for the most advanced US and UK research initiatives in the field.
With one in four Americans currently suffering from a mental health issue, new therapies that offer lasting benefits are needed now more than ever. Although new studies into psychedelics-assisted psychotherapy offer promising relief for a variety of mental illnesses, due to their classification as Schedule I drugs, the research currently depends on the support of a few private donors and institutions.
Fundamental’s first campaign plans to raise funds for ongoing studies on psilocybin & end of life distress, …